Immediate use for the newly developed assembloids could include studying neurodevelopmental disorders such as autism.

The infant was conceived using a workstation that uses AI and robotics to automate the steps required for in vitro ...

Cachexia not only contributes to reduced quality of life but also limits a patient’s ability to tolerate or benefit from standard treatments.

Researchers have identified mutated proteins strongly linked to bone cancer by constructing a multimodal map of human ...

The PRRDetect algorithm identifies tumors with faulty DNA repair mechanisms known as post-replicative repair dysfunction or PRRd.

Kiji Therapeutics Engineered MSCs + IL-10 and CXCR4 offer tighter targeting and greater potency for challenging inflammatory diseases.

To prevent dominance by an acknowledged adversary, the National Security Commission on Emerging Biotechnology (NSCEB) calls for a two-track strategy that helps American companies innovate more quickly ...

Emerging AI-based technologies are galvanizing a new generation of data-driven machinery in the biopharmaceutical industry.

Gene editing technologies have cemented their place as a valued method in the biological toolkit used by researchers around the globe.

The Cell Shuttle was designed to help academic cell therapy developers by providing an integrated, automated solution.

Once thought improbable, in vitro human models are demonstrating technological prowess in a growing range of applications.

Four leading companies CTMC, Iovance Therapeutics, KSQ, and TILT Biotherapeutics prognosticate coming successes of new technology approaches to better tumor-infiltrating lymphocyte activities.